Rheumatoid Arthritis

Introduction

Rheumatoid arthritis, often shortened to RA, is a long-term autoimmune condition that causes the immune system to attack the lining of the joints. The result is pain, swelling, stiffness, and over time, possible damage to the joints and other parts of the body. RA is not the same as the “wear-and-tear” arthritis (osteoarthritis) that develops with age, even though both conditions can affect similar joints.

If you have recently been diagnosed with RA, or you are in the process of being evaluated for it, this guide is written for you. It explains what RA is, why it happens, how doctors confirm the diagnosis, and what current treatment looks like. It also covers what to expect as you live with the condition, how it is monitored over time, and the questions patients most often ask.

Rheumatology — the medical specialty that manages RA — has changed dramatically over the past two decades. Earlier diagnosis, treat-to-target strategies, and a wider range of medicines mean that many people with RA today are able to control their disease well, protect their joints, and continue to live full lives.

What Is Rheumatoid Arthritis?

Rheumatoid arthritis is a chronic inflammatory disease that mainly affects the joints. In a healthy joint, the lining (called the synovium) is thin and produces a small amount of fluid that keeps movement smooth. In RA, the immune system — which normally defends the body against infection — mistakenly targets this lining. The synovium becomes thick, inflamed, and painful. Over time, this ongoing inflammation can wear away cartilage, erode bone, and change the shape of the joint.

RA usually affects joints on both sides of the body in a similar pattern. The small joints of the hands, wrists, and feet are typical first sites, but knees, ankles, elbows, shoulders, hips, and the joints of the neck can also be involved. Because RA is a systemic disease — meaning the inflammation is in the body, not just the joints — it can also affect the eyes, lungs, heart, blood vessels, and skin in some people.

Two features distinguish RA from many other forms of arthritis:

• It is autoimmune. The immune system itself drives the joint damage.
• It is progressive if untreated. Without effective treatment, joint damage tends to build up over months and years.

This is why rheumatologists place strong emphasis on starting treatment early, often within weeks of diagnosis. The first months and years of RA are sometimes called the “window of opportunity,” when treatment is most likely to prevent lasting damage.

Types of Rheumatoid Arthritis

RA is often grouped into categories based on blood tests and clinical pattern. These categories help guide treatment and give some idea of the likely course.

Seropositive RA

About two-thirds of people with RA have positive blood tests for rheumatoid factor (RF), anti-citrullinated protein antibodies (anti-CCP), or both. This is called seropositive RA. It tends to be associated with more aggressive joint disease and a higher chance of complications outside the joints.

Seronegative RA

Some people meet the clinical picture of RA but have negative blood tests for RF and anti-CCP. This is seronegative RA. The course is variable; some people have milder disease, while others have a pattern very similar to seropositive RA.

Early vs. established RA

Doctors also separate “early RA” (typically under six months from symptom onset) from established disease. Early RA is treated with particular urgency, because controlling inflammation in this window has the strongest effect on long-term outcomes.

Juvenile idiopathic arthritis

Arthritis that starts in childhood is usually called juvenile idiopathic arthritis (JIA) rather than RA. JIA is a related but distinct group of conditions, covered in its own section later in this article.

Causes and Risk Factors

The exact cause of RA is not fully known. Most researchers describe it as a combination of genetic susceptibility and environmental triggers that together cause the immune system to start attacking joint tissue.

Genetic factors

Certain genes, particularly in the HLA (human leukocyte antigen) family, are linked to a higher risk of RA. Having a close family member with RA increases your risk, but most people with these genes never develop the disease.

Smoking

Smoking is the most clearly established environmental risk factor for RA. It increases the risk of developing the disease, particularly seropositive RA, and is linked to more severe disease and a poorer response to treatment.

Sex and hormones

RA is roughly two to three times more common in women than in men. Hormonal factors are thought to play a role, although the picture is complex. RA can begin at any age but most commonly starts between the ages of 30 and 60.

Other contributors

• Obesity is associated with a higher risk of RA and may reduce how well treatment works.
• Long-term exposure to silica dust and certain occupational pollutants has been linked to higher risk.
• Gum disease (periodontitis), particularly involving the bacterium Porphyromonas gingivalis, is an area of active research as a possible trigger.
• Viral and bacterial infections have been proposed as triggers in genetically susceptible people, but no single infection has been confirmed as a cause.

If you are reading this after a diagnosis, you are likely already familiar with some of these symptoms. The list below is offered partly to confirm what you have experienced, and partly so you can recognise a flare (a worsening of disease activity) or new involvement of other joints if it happens later.

Typical joint symptoms

• Pain and tenderness in joints, often on both sides of the body
• Swelling and warmth around affected joints
• Morning stiffness that lasts longer than 30 to 60 minutes
• Stiffness after sitting still for a long time
• Reduced grip strength and difficulty with fine hand tasks

Whole-body symptoms

• Persistent fatigue, sometimes severe
• Low-grade fever
• Loss of appetite and unintended weight loss
• A general feeling of being unwell

Less common but important symptoms

• Firm lumps under the skin (rheumatoid nodules), often near the elbows or fingers
• Dry eyes and dry mouth (which may indicate overlap with Sjögren’s syndrome)
• Shortness of breath or persistent cough (possible lung involvement)
• Eye redness, pain, or visual changes (possible scleritis or uveitis)
• Numbness, tingling, or weakness in the hands or feet

If you notice any of these less common symptoms, it is important to mention them to your rheumatologist promptly. They may indicate that RA is affecting organs beyond the joints and may change how treatment is planned.

Diagnosis

RA is diagnosed clinically, meaning the rheumatologist puts together your history, physical examination, and a set of tests rather than relying on a single result. There is no single blood test that says “yes” or “no” to RA.

Clinical assessment

Your doctor will ask about the pattern of joint involvement, how long symptoms have been present, morning stiffness, fatigue, and any whole-body symptoms. Examination focuses on which joints are swollen and tender, range of motion, and signs of disease outside the joints.

Blood tests

• Rheumatoid factor (RF) — an antibody found in many but not all people with RA.
• Anti-cyclic citrullinated peptide (anti-CCP) — a more specific antibody. When positive, it strongly supports an RA diagnosis.
• ESR (erythrocyte sedimentation rate) and CRP (C-reactive protein) — markers of inflammation. They may be raised in active RA but can also be normal.
• Full blood count, kidney and liver function tests — baseline tests before starting medication.

Imaging

• X-rays of the hands and feet, used as a baseline and to monitor for joint damage over time.
• Ultrasound can detect synovitis (inflamed joint lining) and small erosions that X-rays may miss.
• MRI is sometimes used to detect very early inflammation or assess specific joints.

Classification criteria

The 2010 ACR/EULAR classification criteria are widely used to support the diagnosis of RA. They consider the number and size of involved joints, antibody results, inflammation markers, and how long symptoms have lasted. These criteria are tools to help doctors confirm RA and are not used by patients to self-diagnose.

Treatment and Management

Modern RA care follows a strategy called “treat to target.” This means the rheumatologist sets a clear goal — usually remission, or at least low disease activity — and adjusts medications regularly until that goal is met and maintained. Both the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR) recommend this approach.

Treatment usually combines:

• Medicines that slow or stop the disease (disease-modifying drugs)
• Medicines that control pain and inflammation in the short term
• Physical and occupational therapy
• Lifestyle changes
• Regular monitoring and adjustment

Conventional DMARDs

Disease-modifying anti-rheumatic drugs (DMARDs) are the foundation of RA treatment. They do not just relieve symptoms — they reduce the underlying immune activity that damages joints.

• Methotrexate is the first-line DMARD recommended by major rheumatology guidelines for most newly diagnosed patients. It is taken once a week, by mouth or as an injection, alongside folic acid to reduce side effects.
• Sulfasalazine and leflunomide are alternative DMARDs, sometimes used when methotrexate is not suitable or not tolerated.
• Hydroxychloroquine may be used in milder disease or in combination with other DMARDs.

It can take six to twelve weeks for these medicines to show their full effect. During this time, doctors typically use other medicines to bridge the gap.

Biologic DMARDs

Biologics are newer, targeted treatments designed to block specific parts of the immune system that drive RA. They are given as injections under the skin or as infusions into a vein. Guidelines generally recommend biologics when conventional DMARDs alone have not controlled the disease.

• TNF inhibitors such as adalimumab, etanercept, infliximab, golimumab, and certolizumab
• IL-6 inhibitors such as tocilizumab and sarilumab
• B-cell depleting therapy such as rituximab
• T-cell costimulation blockers such as abatacept

Biosimilar versions of several biologics are now widely available and are used in the same way as the original products.

Targeted synthetic DMARDs (JAK inhibitors)

Janus kinase (JAK) inhibitors, including tofacitinib, baricitinib, and upadacitinib, are tablets that interfere with internal signalling pathways inside immune cells. They are an option when conventional DMARDs have not worked. Because of safety considerations in certain groups (older patients, smokers, people with cardiovascular risk factors, or a history of blood clots or certain cancers), rheumatologists carefully assess suitability before prescribing them.

Short-term medicines for symptom control

• Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can reduce pain and stiffness but do not slow the disease.
• Corticosteroids (such as prednisolone) are powerful anti-inflammatory medicines used for short periods — for example, to settle a flare or while waiting for DMARDs to take effect. Current guidelines favour using the lowest dose for the shortest possible time, because of side effects with long-term use.

Physical and occupational therapy

Working with a physiotherapist or occupational therapist is a recognised part of RA care. They can help with:

• Exercises to maintain joint range of motion and muscle strength
• Pacing and energy management for fatigue
• Splints and supports for affected joints, especially the hands and wrists
• Adaptations to daily tasks at home and at work

Surgery

Surgery is a smaller part of RA care than it once was, because medications now prevent severe damage in many patients. When it is needed, options include joint replacement (most often hip or knee), tendon repair, and procedures on the wrists or feet to correct deformity or relieve pain.

Lifestyle and Self-Management

Medicines do most of the work in controlling RA, but daily habits genuinely affect how you feel and how well treatment works.

Physical activity

Regular movement is one of the most consistent recommendations across rheumatology guidelines. Activity helps maintain joint flexibility, builds muscle that supports the joints, improves mood, and reduces cardiovascular risk — which is higher in people with RA.

A balanced programme typically includes:

• Low-impact aerobic exercise such as walking, cycling, or swimming
• Strength training appropriate to your current ability
• Range-of-motion and flexibility exercises
• Gentle activities like yoga or tai chi for stiffness and balance

During a flare, exercise can usually continue at a gentler level. A physiotherapist can help adjust your routine.

Diet

There is no single “RA diet,” but a Mediterranean-style pattern — vegetables, fruits, whole grains, fish, olive oil, nuts, and limited red and processed meat — is often suggested. Omega-3 fatty acids, found in oily fish or fish-oil supplements, have shown modest benefit in some studies. Maintaining a healthy weight reduces stress on weight-bearing joints and may improve treatment response.

Stopping smoking

Stopping smoking is one of the most important steps a person with RA can take. It is linked to better treatment response, lower disease activity, and reduced risk of complications, including lung and heart disease.

Sleep, stress, and mental health

Pain and fatigue can disturb sleep, and poor sleep tends to worsen pain — a difficult cycle. Stress can also trigger flares. Techniques such as cognitive behavioural therapy, mindfulness, relaxation training, and counselling are increasingly recognised as part of comprehensive RA care. Depression and anxiety are more common in people with RA, and treating them improves overall outcomes.

Vaccinations and infection prevention

Because RA itself and many of its treatments affect the immune system, vaccinations are an important part of care. Your rheumatologist will usually recommend staying up to date with influenza, pneumococcal, and other vaccines as appropriate, and will advise on timing around biologic therapy.

Monitoring and Targets

RA is a moving target. Disease activity can shift over months and years, and treatment is adjusted accordingly.

Disease activity scores

Rheumatologists use structured scoring tools to measure how active the disease is. The most widely used is the DAS28, which combines the number of swollen and tender joints (out of 28), an inflammation blood test, and the patient’s own assessment of how they feel. Other tools include the CDAI and SDAI. These scores guide whether to continue, escalate, or de-escalate treatment.

Routine tests

Depending on which medicines you take, you may need blood tests every few weeks at the start and then every one to three months. These check:

• Inflammation markers (ESR, CRP)
• Blood counts
• Liver and kidney function

Imaging

X-rays of the hands and feet may be repeated periodically to look for new or progressing joint damage. Ultrasound is increasingly used in many clinics to assess inflammation in specific joints.

Treatment targets

The standard target across modern guidelines is sustained remission — minimal or no signs of active disease. For some patients, particularly those with long-standing disease, low disease activity is an acceptable alternative target. Reaching and holding that target is the long-term goal of treatment.

Complications

Well-controlled RA causes fewer complications than uncontrolled disease, but it remains a systemic illness. Being aware of possible complications helps you and your rheumatologist watch for them.

Joint complications

• Loss of cartilage and bone erosion
• Joint deformity, particularly in the hands and feet
• Reduced grip strength and difficulty with daily tasks
• Neck pain or instability if the cervical spine is involved

Cardiovascular disease

People with RA have a higher risk of heart attack, stroke, and other cardiovascular conditions, partly because of long-term inflammation. Blood pressure, cholesterol, blood sugar, and smoking status are typically reviewed regularly.

Lung disease

Bone thinning (osteoporosis)

RA itself, reduced activity, and corticosteroid use can all contribute to osteoporosis. Bone density may be monitored, and calcium, vitamin D, or bone-protecting medicines may be advised.

Eye involvement

Dry eyes are common. Less commonly, RA can cause scleritis (a serious inflammation of the white of the eye), which needs urgent evaluation.

Infection risk

Both the disease and many of its treatments increase the risk of certain infections. Vaccinations, prompt evaluation of new fevers, and screening for tuberculosis and hepatitis before starting biologics are standard parts of care.

Mental health

Depression, anxiety, and chronic fatigue are more common in people with RA. They are real medical issues, not personal weakness, and they respond to treatment.

Other long-term effects

Rarely, RA can cause inflammation of small blood vessels (rheumatoid vasculitis), affect the heart valves or sac around the heart, or contribute to anaemia of chronic disease.

Living with Rheumatoid Arthritis

RA changes daily life, but most people find that with effective treatment and time, they adjust to a new routine that works for them.

Work

Many people with RA continue to work, though some find that physically demanding jobs or long, fixed postures become difficult. Adjustments may include ergonomic equipment, flexible hours, and breaks to move and stretch. Occupational therapists can advise on workplace adaptations.

Family and relationships

Pain, fatigue, and treatment schedules affect not only you but the people around you. Honest conversations about energy limits, household tasks, and what helps and hurts are valuable. Family members often want to support you but may not know how; specific requests are easier to act on than general ones.

Pregnancy and family planning

Many women with RA have successful pregnancies, but planning is important. Some medications used for RA are not safe in pregnancy, while others can be continued or substituted. If you are planning a pregnancy, or could become pregnant, discuss this with your rheumatologist well in advance so that your treatment plan can be adjusted safely. Disease activity often improves during pregnancy and may flare in the months after delivery.

Emotional health

Travel

RA does not generally restrict travel, but planning matters: carrying medicines (including injections) in original packaging with a letter from your doctor, allowing extra time for stiffness, and planning rest into your itinerary all help.

Rheumatoid Arthritis in Children

Arthritis that begins before the age of 16 is called juvenile idiopathic arthritis (JIA), not rheumatoid arthritis. JIA is actually a group of conditions that differ in pattern and severity. Some forms involve only a few joints; others involve many joints; some involve fevers, rash, and whole-body inflammation; and a smaller group resembles adult RA, including being positive for rheumatoid factor.

Key points for parents:

• JIA is diagnosed and managed by a paediatric rheumatologist, sometimes alongside an ophthalmologist because some forms of JIA can affect the eyes silently.
• Treatment principles overlap with adult RA — early use of DMARDs, biologics when needed, physical and occupational therapy, and regular monitoring — but doses, drug choices, and follow-up patterns are tailored to children.
• Many children with JIA achieve remission. Some grow out of the disease; others continue to need treatment as adults.
• School, sport, and friendships are an important part of care. With good control, most children can take part in normal activities.

If your child has been diagnosed with JIA, the paediatric rheumatology team will guide you through the specific plan and what to expect.

Preventing Progression and Complications

There is no proven way to prevent RA itself, but once the diagnosis is made, much can be done to limit damage and complications.

• Start treatment early. The earlier effective treatment begins, the better the long-term joint outcomes tend to be.
• Take medicines as prescribed. Stopping DMARDs or biologics without discussion can trigger flares and lasting joint damage.
• Attend regular reviews. Disease activity changes; treatment should change with it.
• Stop smoking. This is one of the strongest modifiable factors in RA outcomes.
• Manage cardiovascular risk. Blood pressure, cholesterol, weight, and diabetes screening are part of overall RA care.
• Protect your bones. Discuss calcium, vitamin D, weight-bearing exercise, and bone-density testing with your rheumatologist, especially if you are taking corticosteroids.
• Stay up to date with vaccinations as advised by your doctor.

When to Seek Urgent Care

Most RA care happens in scheduled clinic visits. Certain situations, however, deserve prompt or urgent attention:

• Sudden severe pain, swelling, or redness in a single joint (which may indicate infection)
• High fever, chills, or feeling very unwell, especially while on immune-suppressing medication
• New chest pain or significant shortness of breath
• Sudden severe eye pain, eye redness with vision changes, or sudden vision loss
• Sudden weakness, numbness, or severe headache
• Unusual bruising, persistent bleeding, or signs of severe medication side effects

If you are unsure whether a symptom is urgent, contact your rheumatology team or seek medical care — it is better to be checked and reassured.

Frequently Asked Questions

Is rheumatoid arthritis curable?

There is currently no cure for RA, but it is highly treatable. With modern medicines, many people achieve remission — a state where the disease is inactive or nearly so — and live with very few day-to-day symptoms. Treatment is usually long-term, sometimes lifelong.

Will I have to take medication forever?

Many people with RA need ongoing treatment, although doses can sometimes be reduced once stable remission has been maintained for a long period. Stopping medication completely is sometimes possible but is associated with a risk of flare. Decisions about tapering or stopping are made together with your rheumatologist based on disease activity and overall stability.

Are biologics and JAK inhibitors safe?

These medicines have transformed RA outcomes, but like all powerful treatments they have risks, including a higher chance of certain infections. Before starting, rheumatologists usually screen for tuberculosis, hepatitis, and other conditions, and they monitor blood tests regularly afterwards. JAK inhibitors carry specific cardiovascular and blood-clot considerations that are weighed carefully, particularly in older patients and those with risk factors.

Can diet alone treat RA?

Diet can support overall health and may modestly affect symptoms, but no diet has been shown to replace disease-modifying medication. A balanced, Mediterranean-style pattern is often suggested as part of a broader plan.

Is exercise safe if my joints hurt?

For most people with RA, regular activity is encouraged. It does not damage joints when done appropriately and tends to reduce stiffness and pain over time. During severe flares, exercise may need to be gentler. A physiotherapist can help design a programme suited to your stage of disease.

Does cold or rainy weather make RA worse?

Many people notice that joints feel stiffer or more painful in cold or damp weather. Studies on this are mixed, but the experience is common and real. Weather does not change the underlying disease activity.

Will my children get RA?

RA is not strictly inherited, but having a close relative with RA does modestly raise the risk. Most children of people with RA will never develop it. Avoiding smoking is one practical step that lowers risk.

Can RA affect parts of the body other than joints?

Yes. RA is a systemic disease and can affect the lungs, heart, blood vessels, eyes, skin, and other tissues. These complications are less common when disease activity is well controlled, which is one of the reasons that ongoing monitoring matters.

How long does it take for treatment to work?

Conventional DMARDs such as methotrexate generally take six to twelve weeks to reach their full effect. Biologics often work more quickly, sometimes within weeks. During the waiting period, short courses of corticosteroids or NSAIDs may be used to control symptoms.

Conclusion

Rheumatoid arthritis is a chronic autoimmune disease, but it is no longer a condition where steady decline is the expected outcome. With earlier diagnosis, treat-to-target strategies, and a wider range of effective medicines, many people with RA today maintain stable, low-activity disease for years and continue with the work, relationships, and activities that matter to them.

The most important factors are early evaluation by a rheumatologist, starting disease-modifying treatment promptly, regular monitoring, and addressing the wider effects of the condition — on cardiovascular health, bones, mood, and daily life. The plan is personal: which medicines, in which combinations, with which lifestyle supports, is a conversation between you and your rheumatology team, revisited as your disease evolves.

RA asks for patience and partnership. With both, the long-term outlook for most people is far better than it would have been even a generation ago.